Campbell & Co Investment Adviser’s Oric Pharmaceuticals ORIC Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$378K	Buy	+29,815	New	+$338K	0.02%	823
2025 Q4	–	Sell	-13,970	Closed	-$168K	–	1332
2025 Q3	$168K	Sell	13,970 -5,698	-29%	-$59.9K	0.01%	1025
2025 Q2	$200K	Buy	+19,668	New	+$132K	0.01%	1057
2024 Q4	–	Sell	-27,241	Closed	-$279K	–	1279
2024 Q3	$279K	Buy	+27,241	New	+$269K	0.02%	928
2024 Q2	–	Sell	-96,468	Closed	-$1.33M	–	1273
2024 Q1	$1.33M	Buy	96,468 +58,849	+156%	+$699K	0.11%	279
2023 Q4	$346K	Buy	+37,619	New	+$272K	0.03%	863

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Campbell & Co Investment Adviser's ORIC Position: Q1 2026 in Review

Campbell & Co Investment Adviser opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 29,815 shares worth $378K. The stake represents 0.02% of the portfolio and ranks #823 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in ORIC as recently as Q3 2025.

Campbell & Co Investment Adviser first reported a position in ORIC in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.33M in Q1 2024. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

Campbell & Co Investment Adviser held 29,815 shares of Oric Pharmaceuticals worth $378K as of Q1 2026.
Oric Pharmaceuticals was a new Campbell & Co Investment Adviser position in Q1 2026.
Oric Pharmaceuticals made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #823 holding.
Campbell & Co Investment Adviser first reported a position in Oric Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
Campbell & Co Investment Adviser's Oric Pharmaceuticals position peaked at $1.33M in Q1 2024.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.